Porustobart clinical trials

Neoadjuvant Pembrolizumab and Porustobart in Resectable pMMR/MSS Colon Cancer

This study is testing two medicines, Pembrolizumab and Porustobart, for a common type of colon cancer before surgery. The aim is to see if these medicines help the immune system fight the cancer and how safe they are. It’s for adults whose cancer can be removed by surgery and hasn’t spread.